Biocompatibility and degradation of an injectible nano-sized composite bone substitute

Academic Journal of Second Military Medical University

Volumn 27, Issue 10, 2006, Pages 1121-1126

  Ge, Liang ^a   Gou, San Huai ^a   Yang, Si Chuan ^b   Wang, Shi Long ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b TONGJI UNIVERSITY   (China)

Author keywords

Bioabsorption; Biocompatibility; Bone substitute; Calcium sulphate; Hydroxyapatites; Injections; Nanotechnology

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CALCIUM SULFATE; EOSIN; HEMATOXYLIN; HYDROXYAPATITE; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCOMPATIBILITY; BIODEGRADATION; BODY WEIGHT; BONE DEFECT; BONE PROSTHESIS; BONE RADIOGRAPHY; BONE REGENERATION; CELL PROLIFERATION; COMPOSITE MATERIAL; CONTROLLED STUDY; CYTOTOXICITY; FIBROBLAST; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; MUSCLE DISEASE; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS; RABBIT;

EID: 33750469376     PISSN: 0258879X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Wang X, Li Y, Wei J, et al. Development of biomimetic nanohydroxyapatite/ poly (hexamethylene adipamide) composites [J]. Biomaterials,2002,23:4787-4791.
2. Webster TJ, Ergun C, Doremus RH, et al. Enhanced osteoclast-like cell function on nanophase ceramics [J]. Biomaterials, 2001,22:1327-1333.
3. Walsh WR, Chapman-Sheath PJ, Cain S, et al. A resorbable porous ceramic composite bone graft substitute in a rabbit metaphyseal defect model[J]. J Orthop Res,2003,21: 655-661.
4. Frame JW, Rout PG, Browne RM. Ridge augmentation using solid and porous hydroxyapatite particles with and without antogenous bone or plaster[J]. J Oral Maxiallofac Surg, 1987,45: 771-778.
5. Turner TM, Urban RM, Hall DJ, et al. Osseous healing using injectable calcium sulfate-based putty for the delivery of demineralized bone matrix and cancellous bone chips[J]. Orthopedics,2003,26(5 Suppl): S571-S575.
6. Turner T, Urban R, Tomlinson M, et al. Early restoration of bone following vertebroplasty using a high strength injectable calcium sulfate bone graft substitute compared to polymethyl-methacrylate[J]. Spine J,2004,4(5 Suppl 1): S106-S107.
7. Sato S, Koshino T, Saito T. Osteogenic response of rabbit tibia to hydroxyapatite particle-plaster of Paris mixture[J]. Biomaterials,1998,19:1895-1900.
8. Yang DA, Yang Z, Li X, et al. A study of hydroxyapatite/calcium sulphate bioceramics[J]. Ceram Int,2005,31:1021-1023.
9. Chinese source. 2006,1:16-17.
10. Chinese source. 2001:233-235.
11. Chinese source. 2005,22:463-467.
12. Delloye C, Cnockaert N, Cornu O. Bone substitutes in 2003: an overview[J]. Acta Orthop Belg,2003,69:1-8.
13. Nilsson M, Wang JS, Wielanek L, et al. Biodegradation and biocompatability of a calcium sulphate-hydroxyapatite bone substitute[J]. J Bone Joint Surg Br,2004,86:120-125.
14. Bell WH. Resorption characteristics of bone and plaster[J]. J Dent Res,1960,39:727-734.
15. Turner TM, Urban RM, Gitelis S, et al. Resorption evaluation of a large bolus of calcium sulfate in a canine medullary defect [J]. Orthopedics,2003,26(5 Suppl): S577-S579.
16. Stubbs D, Deakin M, Chapman-Sheath P, et al. In vivo evaluation of resorbable bone graft substitutes in a rabbit tibial defect model[J]. Biomaterials,2004,25:5037-5044.